Iodine Bonded with Milk Protein Inhibits Benign Prostatic Hyperplasia Development in Rats.

作者: Vladimir G Bespalov , Valerii A Alexandrov , Grigory V Tochilnikov , Dmitrii E Lukin , Nadezhda T Zhilinskaya

DOI: 10.2174/1871520619666190705143927

关键词:

摘要: Background There is some evidence that Benign Prostatic Hyperplasia (BPH) may increase the risk of developing prostate cancer, so conducting research on effective BPH inhibitors important. Objective This studied inhibitory effect Iodized Serum Milk Protein (ISMP) in rats. ISMP a concentrate lactic protein containing 2.2% iodine. Methods Male Wistar rats, aged 18 months, were used. In intact control group, sunflower oil was administered intragastrically by gavage. 36 induced surgical castration, followed subcutaneous injections prolonged testosterone - omnadren, 25mg/kg every other day (7 administrations). One group rats served as BPH-control. and finasteride (positive control), dissolved oil, to daily at dose 200μg/kg 5mg/kg, respectively, for 4 weeks starting immediately after castration. Results inhibited development significantly reducing mass its parts (except anterior lobes) 1.1-1.3 times prostatic index (the ratio weight body weight) 1.3-1.4 times. Finasteride BPH, activity higher (by times) than ISMP. Histological analysis showed fewer pronounced morphological hyperplasia signs animals treated with or finasteride. Conclusion The iodine-containing preparation has ability inhibit although somewhat lower

参考文章(27)
Ciro Servadio, Marisa D. Scolnik, Armand Abramovici, Comparative study of experimentally induced benign and atypical hyperplasia in the ventral prostate of different rat strains. Journal of Andrology. ,vol. 15, pp. 287- 297 ,(1994) , 10.1002/J.1939-4640.1994.TB00451.X
Paloma Olvera-Caltzontzin, Guadalupe Delgado, Carmen Aceves, Brenda Anguiano, Iodine uptake and prostate cancer in the TRAMP mouse model. Molecular Medicine. ,vol. 19, pp. 409- 416 ,(2013) , 10.2119/MOLMED.2013.00093
David D. Ørsted, Stig E. Bojesen, The link between benign prostatic hyperplasia and prostate cancer Nature Reviews Urology. ,vol. 10, pp. 49- 54 ,(2013) , 10.1038/NRUROL.2012.192
Carmen Aceves, Brenda Anguiano, Guadalupe Delgado, The Extrathyronine Actions of Iodine as Antioxidant, Apoptotic, and Differentiation Factor in Various Tissues Thyroid. ,vol. 23, pp. 938- 946 ,(2013) , 10.1089/THY.2012.0579
Saiful Miah, James Catto, BPH and prostate cancer risk Indian Journal of Urology. ,vol. 30, pp. 214- 218 ,(2014) , 10.4103/0970-1591.126909
Nuri Aranda, Susana Sosa, Guadalupe Delgado, Carmen Aceves, Brenda Anguiano, Uptake and antitumoral effects of iodine and 6-iodolactone in differentiated and undifferentiated human prostate cancer cell lines. The Prostate. ,vol. 73, pp. 31- 41 ,(2013) , 10.1002/PROS.22536
Michele Navarra, Salvatore Micali, Saverio M. Lepore, Anna Maria Cesinaro, Marilena Celano, Maria C. Sighinolfi, Carmela De Gaetani, Sebastiano Filetti, Giampaolo Bianchi, Diego Russo, Expression of the Sodium/Iodide Symporter in Human Prostate Adenocarcinoma Urology. ,vol. 75, pp. 773- 778 ,(2010) , 10.1016/J.UROLOGY.2009.10.011
David D. Ørsted, Stig E. Bojesen, Sune F. Nielsen, Børge G. Nordestgaard, Association of Clinical Benign Prostate Hyperplasia with Prostate Cancer Incidence and Mortality Revisited: A Nationwide Cohort Study of 3 009 258 Men European Urology. ,vol. 60, pp. 691- 698 ,(2011) , 10.1016/J.EURURO.2011.06.016
David G. Bostwick, William H. Cooner, Louis Denis, George W. Jones, Peter T. Scardino, Gerald P. Murphy, The association of benign prostatic hyperplasia and cancer of the prostate Cancer. ,vol. 70, pp. 291- 301 ,(1992) , 10.1002/1097-0142(19920701)70:1+<291::AID-CNCR2820701317>3.0.CO;2-4
Paola Lucia Minciullo, Antonino Inferrera, Michele Navarra, Gioacchino Calapai, Carlo Magno, Sebastiano Gangemi, Oxidative stress in benign prostatic hyperplasia: a systematic review. Urologia Internationalis. ,vol. 94, pp. 249- 254 ,(2015) , 10.1159/000366210